Cargando…

Pulmonary Hypertension in Patients With Heart Failure With Mid-Range Ejection Fraction

Pulmonary hypertension (PH) is common in patients with heart failure (HF). The role of PH in patients with HF with reduced (HFrEF) and preserved (HFpEF) left ventricular ejection fraction (LVEF) has been extensively characterized during the last years. In contrast, the pathophysiology of HF with mid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maeder, Micha T., Weber, Lukas, Buser, Marc, Brenner, Roman, Joerg, Lucas, Rickli, Hans
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298862/ https://www.ncbi.nlm.nih.gov/pubmed/34307506 http://dx.doi.org/10.3389/fcvm.2021.694240

Ejemplares similares

Pulmonary Hypertension in Aortic and Mitral Valve Disease
por: Maeder, Micha T., et al.
Publicado: (2018)

Central and Obstructive Apneas in Heart Failure With Reduced, Mid-Range and Preserved Ejection Fraction
por: Borrelli, Chiara, et al.
Publicado: (2019)

Heart Failure With Mid-range Ejection Fraction: Every Coin Has Two Sides
por: Zhu, Kaiyuan, et al.
Publicado: (2021)

Treatment of Heart Failure With Mid-Range Ejection Fraction: A Summary of Current Evidence
por: Ma, Teng, et al.
Publicado: (2021)

Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?
por: Zhou, Qing, et al.
Publicado: (2021)

Hemodynamics Prior to Valve Replacement for Severe Aortic Stenosis and Pulmonary Hypertension during Long-Term Follow-Up
por: Weber, Lukas, et al.
Publicado: (2021)

Diagnosing heart failure with preserved ejection fraction with pulmonary vascular disease
por: Maeder, Micha T
Publicado: (2023)

The Value of IGF-1 and IGFBP-1 in Patients With Heart Failure With Reduced, Mid-range, and Preserved Ejection Fraction
por: Guo, Shaohua, et al.
Publicado: (2022)

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain)
por: Farré, Nuria, et al.
Publicado: (2017)

Heart Failure with Mid-Range Ejection Fraction - State of the Art
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019)

Heart rate in heart failure with mid-range ejection fraction
por: Yılmaz, Mehmet Birhan
Publicado: (2019)

Heart failure with mid-range or mildly reduced ejection fraction
por: Savarese, Gianluigi, et al.
Publicado: (2021)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Alkhodari, Mohanad, et al.
Publicado: (2021)

Wedge Pressure vs Left Ventricular End-Diastolic Pressure for Pulmonary Hypertension Classification and Prognostication in Severe Aortic Stenosis
por: Maeder, Micha T., et al.
Publicado: (2021)

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence
por: Koufou, Eleni-Evangelia, et al.
Publicado: (2021)

Systemic blood pressure in severe aortic stenosis: Haemodynamic correlates and long‐term prognostic impact
por: Maeder, Micha T., et al.
Publicado: (2022)

Relationship between B‐type natriuretic peptide and invasive haemodynamics in patients with severe aortic valve stenosis
por: Maeder, Micha T., et al.
Publicado: (2020)

Epicardial fat in heart failure patients with mid‐range and preserved ejection fraction
por: van Woerden, Gijs, et al.
Publicado: (2018)

Heart Failure With Mid-range or Recovered Ejection Fraction: Differential Determinants of Transition
por: Margonato, Davide, et al.
Publicado: (2020)

The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction
por: Bielecka-Dabrowa, Agata, et al.
Publicado: (2017)

Impact of the new pulmonary hypertension definition on long‐term mortality in patients with severe aortic stenosis undergoing valve replacement
por: Maeder, Micha T., et al.
Publicado: (2021)

Heart Failure With Midrange Ejection Fraction: Prior Left Ventricular Ejection Fraction and Prognosis
por: Zhang, Xinxin, et al.
Publicado: (2021)

Reduction of Pulmonary Hypertension After Transition to Sacubitril/Valsartan in Patients With Heart Failure With Preserved Ejection Fraction
por: Burgdorf, Christof, et al.
Publicado: (2021)

Exercise Systolic Reserve and Exercise Pulmonary Hypertension Improve Diagnosis of Heart Failure With Preserved Ejection Fraction
por: Verwerft, Jan, et al.
Publicado: (2022)

Heart failure with mid‐range ejection fraction: characterization of patients from the PINNACLE Registry®
por: Ibrahim, Nasrien E., et al.
Publicado: (2019)

The impact of heart rate on patients diagnosed with heart failure with mid-range ejection fraction
por: Xin, Yanguo, et al.
Publicado: (2019)

Spironolactone use is associated with improved outcomes in heart failure with mid‐range ejection fraction
por: Enzan, Nobuyuki, et al.
Publicado: (2020)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
por: Santas, Enrique, et al.
Publicado: (2020)

Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction
por: van Woerden, Gijs, et al.
Publicado: (2021)

Non-invasive assessment prior to invasive coronary angiography in routine clinical practice in Switzerland – Is it according to the guidelines?
por: Schiefer, Rebecca, et al.
Publicado: (2019)

Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction: The Misleading Definition of the New Guidelines
por: Fedele, Francesco, et al.
Publicado: (2017)

Silent Cerebral Infarctions with Reduced, Mid-Range and Preserved Ejection Fraction in Patients with Heart Failure
por: Oliveira, Márcia Maria Carneiro, et al.
Publicado: (2018)

The prognosis of mid‐range ejection fraction heart failure: a systematic review and meta‐analysis
por: Altaie, Saif, et al.
Publicado: (2018)

Particularities of Older Patients with Obstructive Sleep Apnea and Heart Failure with Mid-Range Ejection Fraction
por: Ardelean, Carmen Loredana, et al.
Publicado: (2019)

Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction
por: Son, Mi Kyoung, et al.
Publicado: (2020)

Impact of diastolic dysfunction on outcome in heart failure patients with mid‐range or reduced ejection fraction
por: Liu, Dan, et al.
Publicado: (2021)

Prognostic value of reverse remodelling criteria in heart failure with reduced or mid‐range ejection fraction
por: Aimo, Alberto, et al.
Publicado: (2021)

Atrial fibrillation ablation in heart failure with mid-range ejection fraction: Is it time to open the champagne?
por: Nagarakanti, Rangadham, et al.
Publicado: (2023)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Editorial: Edema in heart failure with reduced ejection fraction
por: Gladysheva, Inna P., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1pgrdtee1b9jovqe0lghpphmu3